4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-18-002804
Options or other derivatives
- Chief Financial Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kostiner Barry Chief Financial Officer | 2018-10-17 | Grant or award · Option (Right to Buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/form410211002_10192018.xml…